Cited by 494Diabetes Management and ResearchDiabetes Management and EducationDiabetes Treatment and Management

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial

Open access

the SWITCH Study Group, Battelino, T., Conget, I., Olsen, B., Schütz-Fuhrmann, I., Hommel, E., Hoogma, R., Schierloh, U., Sulli, N., Bolinder, J.·2012·Diabetologia

DOI 10.1007/s00125-012-2708-9PMC PMC3483098

Open this paper in CoChat — free account Open PDF

Abstract

AIMS/HYPOTHESIS: The aim of this multicentre, randomised, controlled crossover study was to determine the efficacy of adding continuous glucose monitoring (CGM) to insulin pump therapy (CSII) in type 1 diabetes. METHODS: Children and adults (n = 153) on CSII with HbA(1c) 7.5-9.5% (58.5-80.3 mmol/mol) were randomised to (CGM) a Sensor On or Sensor Off arm for 6 months. After 4 months' washout, participants crossed over to the other arm for 6 months. Paediatric and adult participants were separately electronically randomised through the case report form according to a predefined randomisation sequence in eight secondary and tertiary centres. The primary outcome was the difference in HbA(1c) levels between arms after 6 months. RESULTS: Seventy-seven participants were randomised to the On/Off sequence and 76 to the Off/On sequence; all were included in the primary analysis. The mean difference in HbA(1c) was -0.43% (-4.74 mmol/mol) in favour of the Sensor On arm (8.04% [64.34 mmol/mol] vs 8.47% [69.08 mmol/mol]; 95% CI -0.32%, -0.55% [-3.50, -6.01 mmol/mol]; p < 0.001). Following cessation of glucose sensing, HbA(1c) reverted to baseline levels. Less time was spent with sensor glucose <3.9 mmol/l during the Sensor On arm than in the Sensor Off arm (19 vs 31 min/day; p = 0.009). The mean number of daily boluses increased in the Sensor On arm (6.8 ± 2.5 vs 5.8 ± 1.9, p < 0.0001), together with the frequency of use of the temporary basal rate (0.75 ± 1.11 vs 0.26 ± 0.47, p < 0.0001) and manual insulin suspend (0.91 ± 1.25 vs 0.70 ± 0.75, p < 0.018) functions. Four vs two events of severe hypoglycaemia occurred in the Sensor On and Sensor Off arm, respectively (p = 0.40). CONCLUSIONS/INTERPRETATION: Continuous glucose monitoring was associated with decreased HbA(1c) levels and time spent in hypoglycaemia in individuals with type 1 diabetes using CSII. More frequent self-adjustments of insulin therapy may have contributed to these effects.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1007/s00125-012-2708-9

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Standards of Medical Care in Diabetes
Power, D. V. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,676
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Self-citation
Standards of medical care in diabetes—2011
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s011 · Cited by 2,880
Continuous glucose monitoring and intensive treatment of type 1 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805017 · Cited by 1,559
Self-citation
Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes
Bergenstal, R. M., Tamborlane, W. V., Ahmann, A., Buse, J. B., Dailey, G., Davis, S. N., Joyce, C., Peoples, T., Perkins, B. A., Welsh, J. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002853 · Cited by 894
Modern-Day Clinical Course of Type 1 Diabetes Mellitus After 30 Years' Duration: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications and Pittsburgh Epidemiology of Diabetes Complications Experience (1983-2005)
(2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.193 · Cited by 653
Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta‐analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion
Pickup, J. C., & Sutton, A. J. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02486.x · Cited by 630
Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data
Pickup, J. C., Freeman, S. C., & Sutton, A. J. (2011) · BMJ · doi:10.1136/bmj.d3805 · Cited by 541
Improved Glycemic Control in Poorly Controlled Patients with Type 1 Diabetes Using Real-Time Continuous Glucose Monitoring
Deiss, D., Bolinder, J., Riveline, J.-P., Battelino, T., Bosi, E., Tubiana-Rufi, N., Kerr, D., & Phillip, M. (2006) · Diabetes Care · doi:10.2337/dc06-1134 · Cited by 539
Self-citation
Effect of Continuous Glucose Monitoring on Hypoglycemia in Type 1 Diabetes
Battelino, T., Phillip, M., Bratina, N., Nimri, R., Oskarsson, P., & Bolinder, J. (2011) · Diabetes Care · doi:10.2337/dc10-1989 · Cited by 496
Self-citation

Flagged first, then by citations

Show all 22 references

Sorted by citations

Items 101–200 of 493

Continuous glucose monitoring pilot in low-income type 1 diabetes patients
Sequeira, P. A., Montoya, L., Ruelas, V., Xing, D., Chen, V., Beck, R., & Peters, A. L. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0072 · Cited by 59
Continuous Glucose Monitoring Use in Type 1 Diabetes: Longitudinal Analysis Demonstrates Meaningful Improvements in HbA1c and Reductions in Health Care Utilization
Parkin, C. G., Graham, C., & Smolskis, J. M. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817693253 · Cited by 58
Effect of structured individualized education on continuous glucose monitoring use in poorly controlled patients with type 1 diabetes: a randomized controlled trial
Yoo, J. H., Kim, G., Lee, H. J., Sim, K. H., Jin, S.-M., & Kim, J. H. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109209 · Cited by 58
Routine use of continuous glucose monitoring in 10 501 people with diabetes mellitus
Battelino, T., Liabat, S., Veeze, H. J., Castañeda, J., Arrieta, A., & Cohen, O. (2015) · Diabetic Medicine · doi:10.1111/dme.12825 · Cited by 59
Self-citation
Novel Once-Weekly Basal Insulin Fc Achieved Similar Glycemic Control With a Safety Profile Comparable to Insulin Degludec in Patients With Type 1 Diabetes
Kazda, C. M., Bue-Valleskey, J. M., Chien, J., Zhang, Q., Chigutsa, E., Landschulz, W., Wullenweber, P., Haupt, A., & Dahl, D. (2023) · Diabetes Care · doi:10.2337/dc22-2395 · Cited by 56
Nonadjunctive Use of Continuous Glucose Monitoring for Diabetes Treatment Decisions
Castle, J. R., & Jacobs, P. G. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816631569 · Cited by 58
Sensor-Augmented Insulin Pumps and Hypoglycemia Prevention in Type 1 Diabetes
Steineck, I. I. K., Ranjan, A. G., Nørgaard, K., & Schmidt, S. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816672689 · Cited by 59
Development of Cu nanoflowers modified the flexible needle-type microelectrode and its application in continuous monitoring glucose in vivo
Fang, Y., Wang, S., Liu, Y., Xu, Z., Zhang, K., & Guo, Y. (2018) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2018.03.024 · Cited by 56
Diabetes Technology: Review of the 2019 American Diabetes Association Standards of Medical Care in Diabetes
Chamberlain, J. J., Doyle-Delgado, K., Peterson, L., & SKOLNIK, N. (2019) · Annals of Internal Medicine · doi:10.7326/m19-1638 · Cited by 55
Diagnosis, Therapy and Follow-Up of Diabetes Mellitus in Children and Adolescents
Neu, A., Bürger-Büsing, J., Danne, T., Dost, A., Holder, M., Holl, R. W., Holterhus, P., Kapellen, T. M., Karges, B., Kordonouri, O., et al. (2019) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1018-8963 · Cited by 60
Hypoglycaemia in type 1 diabetes: technological treatments, their limitations and the place of psychology
Choudhary, P., & Amiel, S. A. (2018) · Diabetologia · doi:10.1007/s00125-018-4566-6 · Cited by 52
Severe Hypoglycemia: Is It Still a Threat for Children and Adolescents With Type 1 Diabetes?
Urakami, T. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00609 · Cited by 55
Psychosocial Aspects of Continuous Glucose Monitoring
Kubiak, T., Mann, C. G., Barnard, K., & Heinemann, L. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816651450 · Cited by 49
A Pharmacokinetic Model of a Tissue Implantable Insulin Sensor
Bisker, G., Iverson, N. M., Ahn, J., & Strano, M. S. (2014) · Advanced Healthcare Materials · doi:10.1002/adhm.201400264 · Cited by 48
Influences on Technology Use and Efficacy in Type 1 Diabetes
Franklin, V. L. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816639315 · Cited by 49
From Wary Wearers to d-Embracers: Personas of Readiness to Use Diabetes Devices
Tanenbaum, M. L., Adams, R. N., Iturralde, E., Hanes, S. J., Barley, R. C., Naranjo, D. M., & Hood, K. K. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818793756 · Cited by 49
The use of continuous glucose monitoring systems in a pediatric population with type 1 diabetes mellitus in real-life settings: the AWeSoMe Study Group experience
Rachmiel, M., Landau, Z., Boaz, M., Aronovitch, K. M., Loewenthal, N., Ben‐Ami, M., Levy‐Shraga, Y., Modan‐Moses, D., Haim, A., Abiri, S., et al. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0643-6 · Cited by 45
International consensus on use of continuous glucose monitoring
Danne, T., Nimri, R., Battelino, T., Bergenstal, R. M., Close, K. L., DeVries, J. H., Garg, S. K., Heinemann, L., Hirsch, I. B., Amiel, S. A., et al. (2018) · Yearbook of pediatric endocrinology · doi:10.1530/ey.15.10.10 · Cited by 44
Self-citation
Practical Considerations on the Use of Continuous Glucose Monitoring in Pediatrics and Older Adults and Nonadjunctive Use
Forlenza, G. P., Argento, N. B., & Laffel, L. M. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0034 · Cited by 47
CGM, Pregnancy, and Remote Monitoring
Polsky, S., & Garcetti, R. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0023 · Cited by 43
Continuous Glucose Monitoring in Adults with Type 1 Diabetes: Real-World Data from the German/Austrian Prospective Diabetes Follow-Up Registry
Sandig, D., Grimsmann, J. M., Reinauer, C., Melmer, A., Zimny, S., Müller-Korbsch, M., Forestier, N., Zeyfang, A., Bramlage, P., Danne, T., et al. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0019 · Cited by 43
Shaping Workflows in Digital and Remote Diabetes Care During the COVID-19 Pandemic via Service Design: Prospective, Longitudinal, Open-label Feasibility Trial
Braune, K., Boß, K., Schmidt-Herzel, J., Gajewska, K. A., Thieffry, A., Schulze, L., Posern, B., & Raile, K. (2020) · JMIR mhealth and uhealth · doi:10.2196/24374 · Cited by 48
Biopsychosocial Factors Associated With Satisfaction and Sustained Use of Artificial Pancreas Technology and Its Components: a Call to the Technology Field
Forlenza, G. P., Messer, L. H., Berget, C., Wadwa, R. P., & Driscoll, K. A. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1078-1 · Cited by 43
Emerging Diabetes Technologies: Continuous Glucose Monitors/Artificial Pancreases
ALMURASHI, A. M., Rodriguez, E., & Garg, S. K. (2023) · Journal of the Indian Institute of Science · doi:10.1007/s41745-022-00348-3 · Cited by 55
Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a UK perspective
Roze, S., Smith‐Palmer, J., Valentine, W. J., Cook, M., Jethwa, M., de Portu, S., & Pickup, J. C. (2015) · Journal of Medical Economics · doi:10.3111/13696998.2015.1113979 · Cited by 42
Continuous Glucose Monitoring
van Beers, C. A. J., & DeVries, J. H. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816653411 · Cited by 41
Real-World Data from the First U.S. Commercial Users of an Implantable Continuous Glucose Sensor
Sanchez, P., Ghosh-Dastidar, S., Tweden, K. S., & Kaufman, F. R. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0234 · Cited by 40
The Impact of Continuous Glucose Monitoring on Low Interstitial Glucose Values and Low Blood Glucose Values Assessed by Point-of-care Blood Glucose Meters: Results of a Crossover Trial
Hermanns, N., Schumann, B., Kulzer, B., & Haak, T. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814524105 · Cited by 39
Closed loop insulin delivery in diabetes
Battelino, T., Omladič, J. Š., & Phillip, M. (2015) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2015.03.001 · Cited by 42
Self-citation
Intermittent Use of Continuous Glucose Monitoring: Expanding the Clinical Value of CGM
Ziegler, R., Heinemann, L., Freckmann, G., Schnell, O., Hinzmann, R., & Kulzer, B. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820905577 · Cited by 40
Sustained Impact of Real-time Continuous Glucose Monitoring in Adults With Type 1 Diabetes on Insulin Pump Therapy: Results After the 24-Month RESCUE Study
Charleer, S., Block, C. E. M. D., Nobels, F. R. E., Radermecker, R. P., Lowyck, I., Mullens, A., Scarnière, D., Spincemaille, K., Strivay, M., Weber, E., et al. (2020) · Diabetes Care · doi:10.2337/dc20-1531 · Cited by 39
Use of Glucose Rate of Change Arrows to Adjust Insulin Therapy Among Individuals with Type 1 Diabetes Who Use Continuous Glucose Monitoring
Pettus, J., & Edelman, S. V. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0369 · Cited by 38
Effect of an Integrated, Multidisciplinary Nationwide Approach to Type 1 Diabetes Care on Metabolic Outcomes: An Observational Real-World Study
Lavens, A., Nobels, F. R. E., Block, C. E. M. D., Oriot, P., Verhaegen, A. A., Chao, S., Casteels, K., Mouraux, T., Doggen, K., Mathieu, C., et al. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0003 · Cited by 38
2025 Clinical Practice Guidelines for Diabetes Management in Korea: Recommendation of the Korean Diabetes Association
Kang, S., Kang, S. M., Choi, J. H., Ko, S., Koo, B. K., Kwon, H.-S., Kim, M. K., Kim, S. Y., Kim, S., Kim, Y., et al. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2025.0469 · Cited by 44
Cost-Effectiveness of Sensor-Augmented Pump Therapy with Low Glucose Suspend Versus Standard Insulin Pump Therapy in Two Different Patient Populations with Type 1 Diabetes in France
Roze, S., Smith‐Palmer, J., Valentine, W. J., Payet, V., de Portu, S., Papo, N. L., Cucherat, M., & Hanaire, H. P. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0224 · Cited by 37
Intermittent Fasting Could Be Safely Achieved in People With Type 1 Diabetes Undergoing Structured Education and Advanced Glucose Monitoring
Al‐Ozairi, E., Samad, A. E., Kandari, J. A., & Aldibbiat, A. M. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00849 · Cited by 38
Continuous glucose monitoring with structured education in adults with type 2 diabetes managed by multiple daily insulin injections: a multicentre randomised controlled trial
Kim, J. Y., Jin, S.-M., Sim, K. H., Kim, B.-Y., Cho, J. H., Moon, J. S., Lim, S., Kang, E. S., Park, C.-Y., Kim, S. G., et al. (2024) · Diabetologia · doi:10.1007/s00125-024-06152-1 · Cited by 36
Glycemic Management in Adults With Type 1 Diabetes
McGibbon, A., Adams, L., Ingersoll, K. S., Kader, T., & Tugwell, B. D. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.012 · Cited by 42
Diagnosis, Therapy and Follow-up of Diabetes Mellitus in Children and Adolescents
Neu, A., Bürger-Büsing, J., Danne, T., Dost, A., Holder, M., Holl, R. W., Holterhus, P., Kapellen, T. M., Karges, B., Kordonouri, O., et al. (2019) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0869-0210 · Cited by 36
Improvement in Psychosocial Outcomes in Children with Type 1 Diabetes and Their Parents Following Subsidy for Continuous Glucose Monitoring
Burckhardt, M., Abraham, M. B., Mountain, J. A., Coenen, D., Paniora, J., Clapin, H. F., Jones, T. W., & Davis, E. A. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0149 · Cited by 36
Evaluation of Reference Metrics for Continuous Glucose Monitoring in Persons Without Diabetes and Prediabetes
Sofizadeh, S., Pehrsson, A., Ólafsdóttir, A. F., & Lind, M. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820965599 · Cited by 36
Cardiac Rehab in the COVID Era and Beyond: mHealth and Other Novel Opportunities
Epstein, E., Patel, N., Maysent, K., & Taub, P. R. (2021) · Current Cardiology Reports · doi:10.1007/s11886-021-01482-7 · Cited by 34
Sustained Intensive Treatment and Long-term Effects on HbA1c Reduction (SILVER Study) by CGM in People With Type 1 Diabetes Treated With MDI
Lind, M., Ólafsdóttir, A. F., Hirsch, I. B., Bolinder, J., Dahlqvist, S., Pivodic, A., Hellman, J., Wijkman, M. O., Schwarcz, E., Albrektsson, H., et al. (2020) · Diabetes Care · doi:10.2337/dc20-1468 · Cited by 35
Self-citation
MiniMedTM780G Insulin pump system with smartphone connectivity for the treatment of type 1 diabetes: overview of its safety and efficacy
MCVEAN, J. J. F., & Miller, J. D. (2021) · Expert Review of Medical Devices · doi:10.1080/17434440.2021.1926984 · Cited by 37
Association of HbA1c With All-cause Mortality Across Varying Degrees of Glycemic Variability in Type 2 Diabetes
Lu, J., Wang, C., Cai, J., Shen, Y., Chen, L., Zhang, L., Lu, W., Zhu, W., Hu, G., Xia, T., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab532 · Cited by 33
Accuracy of continuous glucose monitoring in the hospital setting: an observational study
O’Connor, M. Y., Flint, K. L., Sabean, A., Ashley, A. L., Zheng, H., Yan, J., Steiner, B. A., Anandakugan, N., CALVERLEY, M. M., Bartholomew, R. A., et al. (2024) · Diabetologia · doi:10.1007/s00125-024-06250-0 · Cited by 35
Cost‐effectiveness analysis of real‐time continuous monitoring glucose compared to self‐monitoring of blood glucose for diabetes mellitus in Spain
García‐Lorenzo, B., Rivero‐Santana, A., Vallejo‐Torres, L., Castilla‐Rodríguez, I., García‐Pérez, S., García‐Pérez, L., & Perestelo‐Pérez, L. (2018) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.12987 · Cited by 36
Intermittently Scanned and Continuous Glucose Monitor Systems: A Systematic Review on Psychological Outcomes in Pediatric Patients
Franceschi, R., Micheli, F., Mozzillo, E., Cauvin, V., Liguori, A., Soffiati, M., & Giani, E. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.660173 · Cited by 35
Blood Glucose Monitoring in Adults and Children with Diabetes: Update 2021
CHENG, A. Y. Y., Feig, D. S., Ho, J., Siemens, R. L., BAJAJ, H. S., Gilbert, J. D., Houlden, R. L., Kim, J., MacKay, D., Rabi, D. M., et al. (2021) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2021.07.003 · Cited by 36
Patent analysis of digital sensors for continuous glucose monitoring
Litvinova, O., Eitenberger, M., Bilir, A., Yeung, A. W. K., Parvanov, E. D., MohanaSundaram, A., Horbańczuk, J. O., Atanasov, A. G., & Willschke, H. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1205903 · Cited by 37
Utility and precision evidence of technology in the treatment of type 1 diabetes: a systematic review
Jacobsen, L. M., Sherr, J. L., Considine, E. G., Chen, A., Peeling, S., Hulsmans, M., Charleer, S., Urazbayeva, M., Tosur, M., ALAMARIE, S. A., et al. (2023) · Communications Medicine · doi:10.1038/s43856-023-00358-x · Cited by 34
Continuous subcutaneous insulin infusion: Special needs for children
Adolfsson, P., Ziegler, R., & Hanås, R. (2017) · Pediatric Diabetes · doi:10.1111/pedi.12491 · Cited by 30
Multilevel clustering approach driven by continuous glucose monitoring data for further classification of type 2 diabetes
Tao, R., Yu, X., Lu, J., Shen, Y., Lu, W., Zhu, W., Bao, Y., Li, H., & Zhou, J. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001869 · Cited by 31
Sensor and software use for the glycaemic management of insulin-treated type 1 and type 2 diabetes patients
Ajjan, R., Abougila, K., Bellary, S., Collier, A., Franke, B., Jude, E. B., Rayman, G. A., Robinson, A., & Singh, B. M. (2016) · Diabetes and Vascular Disease Research · doi:10.1177/1479164115624680 · Cited by 31
Unblinded CGM Should Replace Blinded CGM in the Clinical Management of Diabetes
Ahn, D. T., Pettus, J., & Edelman, S. V. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816632241 · Cited by 30
Salient Characteristics of Youth with Type 1 Diabetes Initiating Continuous Glucose Monitoring
Teló, G. H., Volkening, L. K., Butler, D. A., & Laffel, L. M. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0290 · Cited by 29
Devices for continuous monitoring of glucose: update in technology
Gómez, A. M., Carrillo, D. C. H., & Múñoz, Ó. (2017) · Medical Devices Evidence and Research · doi:10.2147/mder.s110121 · Cited by 30
Accuracy, satisfaction and usability of a flash glucose monitoring system among children and adolescents with type 1 diabetes attending a summer camp
Hansen, E. A., Klee, P., Dirlewanger, M., Bouthors, T., Elowe-Gruau, É., Stoppa‐Vaucher, S., Phan-Hug, F., Antoniou, M.-C., Pasquier, J., Dwyer, A. A., et al. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12723 · Cited by 28
Unsupervised home use of an overnight closed‐loop system over 3–4 weeks: a pooled analysis of randomized controlled studies in adults and adolescents with type 1 diabetes
Thabit, H., Elleri, D., Leelarathna, L., Allen, J. M., Lubina-Solomon, A., Stadler, M., Walkinshaw, E., Iqbal, A., Choudhary, P., Wilinska, M. E., et al. (2014) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12427 · Cited by 29
Implantable and transcutaneous continuous glucose monitoring system: a randomized cross over trial comparing accuracy, efficacy and acceptance
Boscari, F., Vettoretti, M., Cavallin, F., Amato, A. M. L., Uliana, A., Vallone, V., Avogaro, A., Facchinetti, A., & Bruttomesso, D. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-021-01624-2 · Cited by 28
Assessing the Accuracy of Continuous Glucose Monitoring (CGM) Calibrated With Capillary Values Using Capillary or Venous Glucose Levels as a Reference
Andelin, M., Kropff, J., Matuleviciene, V., Joseph, J. I., Attvall, S., Theodorsson, E., Hirsch, I. B., Imberg, H., Dahlqvist, S., Klonoff, D. C., et al. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815626724 · Cited by 29
Skin Problems Due to Treatment with Technology Are Associated with Increased Disease Burden Among Adults with Type 1 Diabetes
Christensen, M. O., Berg, A. K., Rytter, K., Hommel, E., Thyssen, J. P., Svensson, J., & Nørgaard, K. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0007 · Cited by 28
Self-citation
A New Horizon for Glucose Monitoring
Dovč, K., Bratina, N., & Battelino, T. (2015) · Hormone Research in Paediatrics · doi:10.1159/000368924 · Cited by 27
Self-citation
Design and Methods of a Randomized Trial of Continuous Glucose Monitoring in Persons With Type 1 Diabetes With Impaired Glycemic Control Treated With Multiple Daily Insulin Injections (GOLD Study)
Lind, M., Polonsky, W. H., Hirsch, I. B., Heise, T., Bolinder, J., Dahlqvist, S., Pehrsson, N.-G., & Moström, P. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816642578 · Cited by 27
Self-citation
Freestyle Libre trend arrows for the management of adults with insulin-treated diabetes: A practical approach
Bianchi, C., Aragona, M., Rodia, C., Baronti, W., Gennaro, G., Bertolotto, A., & Prato, S. D. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.10.012 · Cited by 27
Clinical use of a 180‐day implantable glucose sensor improves glycated haemoglobin and time in range in patients with type 1 diabetes
Irace, C., Cutruzzolà, A., Nuzzi, A., Assaloni, R., Brunato, B., Pitocco, D., Tartaglione, L., Molfetta, S. D., Cignarelli, A., Laviola, L., et al. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13993 · Cited by 28
DYNAMIC: Dynamic glucose management strategies delivered through a structured education program improves time in range in a socioeconomically deprived cohort of children and young people with type 1 diabetes with a history of hypoglycemia
Pemberton, J. S., Kershaw, M., Dias, R. P., Idkowiak, J., Mohamed, Z., Saraff, V., Barrett, T. G., Krone, R. E., & Uday, S. (2020) · Pediatric Diabetes · doi:10.1111/pedi.13155 · Cited by 26
Hybrid Closed Loop Using a Do-It-Yourself Artificial Pancreas System in Adults With Type 1 Diabetes
Nanayakkara, N., Sharifi, A., Burren, D., Elghattis, Y., Jayarathna, D. K., & Cohen, N. D. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968231153882 · Cited by 28
Continuous Subcutaneous Insulin Infusion in Italy: Third National Survey
Bruttomesso, D., Laviola, L., Lepore, G., Bonfanti, R., Bozzetto, L., Orsi, E., Blasi, V. D., Girelli, A., Grassi, G., Iafusco, D., et al. (2014) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0242 · Cited by 26
Exploring Parental Experiences of Using a Do-It-Yourself Solution for Continuous Glucose Monitoring Among Children and Adolescents With Type 1 Diabetes: A Qualitative Study
Elbalshy, M. M., Styles, S. E., Crocket, H. R., Galland, B. C., MacKenzie, C., de Bock, M. I., Jefferies, C., Wiltshire, E. J., & Wheeler, B. J. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819895290 · Cited by 27
New guideline of the European Medicines Agency (EMA) on the clinical investigation of medicinal products in the treatment and prevention of diabetes mellitus
der Schueren, B. V., Vrijlandt, P. J. W. S., Thomson, A. L., Janssen, H., & Dunder, K. (2024) · Diabetologia · doi:10.1007/s00125-024-06162-z · Cited by 30
Technology in the Management of Type 1 and Type 2 Diabetes Mellitus: Recent Status and Future Prospects
Biswas, T., Behera, B. K., & Madhu, N. R. (2023) · Springer eBooks · doi:10.1007/978-981-19-0027-3_6 · Cited by 33
Cost-effectiveness of sensor-augmented pump therapy versus standard insulin pump therapy in patients with type 1 diabetes in Denmark
Roze, S., de Portu, S., Smith‐Palmer, J., Delbaere, A., Valentine, W. J., & Ridderstråle, M. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.02.009 · Cited by 24
T1D Exchange Quality Improvement Collaborative: A Learning Health System to Improve Outcomes for All People With Type 1 Diabetes
Weinstock, R. S., Prahalad, P., Rioles, N. A., & Ebekozien, O. A. (2021) · Clinical Diabetes · doi:10.2337/cd21-0032 · Cited by 26
Prevention of hypoglycemia by intermittent-scanning continuous glucose monitoring device combined with structured education in patients with type 1 diabetes mellitus: A randomized, crossover trial
Murata, T., Hosoda, K., Nishimura, K., Miyamoto, Y., Sakane, N., Satoh‐Asahara, N., Toyoda, M., Hirota, Y., Matsuhisa, M., Kuroda, A., et al. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.110147 · Cited by 26
Glycaemic control in people with diabetes following acute myocardial infarction
Esdaile, H., Hill, N. E., Mayet, J., & Oliver, N. S. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110644 · Cited by 28
Differences in Use of Glucose Rate of Change (ROC) Arrows to Adjust Insulin Therapy Among Individuals With Type 1 and Type 2 Diabetes Who Use Continuous Glucose Monitoring (CGM)
Pettus, J., & Edelman, S. V. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816639069 · Cited by 26
Population-Level Impact and Cost-effectiveness of Continuous Glucose Monitoring and Intermittently Scanned Continuous Glucose Monitoring Technologies for Adults With Type 1 Diabetes in Canada: A Modeling Study
Rotondi, M. A., Wong, O. C. Y., Riddell, M. C., & Perkins, B. A. (2022) · Diabetes Care · doi:10.2337/dc21-2341 · Cited by 24
Impact of Frequent and Persistent Use of Continuous Glucose Monitoring (CGM) on Hypoglycemia Fear, Frequency of Emergency Medical Treatment, and SMBG Frequency After One Year
Chamberlain, J. J., Dopita, D., Gilgen, E., & Neuman, A. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815604633 · Cited by 24
Closed-loop insulin delivery: current status of diabetes technologies and future prospects
Majeed, W., & Thabit, H. (2018) · Expert Review of Medical Devices · doi:10.1080/17434440.2018.1503530 · Cited by 24
Continuous glucose monitoring assessment of metabolic control in east African children and young adults with type 1 diabetes: A pilot and feasibility study
Yauch, L. M., Velazquez, E. P., Piloya, T., Mungai, L., Omar, A. A., & Moran, A. (2020) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.135 · Cited by 26
Diabetes mellitus type 1 in childhood
Peterkova, V. A., Shestakova, M. V., Bezlepkina, O. B., Лаптев, Д. Н., Кураева, Т. Л., Mayorov, A. Y., Титович, Е. В., Emel'yanov, A. O., Svetlova, G. N., Eremina, I. A., et al. (2020) · Diabetes Mellitus · doi:10.14341/dm12504 · Cited by 24
Minimizing the Risk of Exercise-Induced Glucose Fluctuations in People Living With Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion: An Overview of Strategies
Molveau, J., RABASA-LHORET, R. P. R., Taleb, N., Heyman, E., Myette‐Côté, É., Suppère, C., Berthoin, S., & Tagougui, S. (2021) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2021.01.003 · Cited by 23
The Effect of Lockdown and Physical Activity on Glycemic Control in Italian Children and Young Patients With Type 1 Diabetes
Minuto, N., Bassi, M., Montobbio, C., Vinci, F., Mercuri, C., Perri, F. N., Cabri, M., Calevo, M. G., d’Annunzio, G., & Maghnie, M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.690222 · Cited by 22
Recommendations for self-monitoring in pediatric diabetes: a consensus statement by the ISPED
Diabetes Study Group of the Italian Society for Pediatric Endocrinology and Diabetology, Scaramuzza, A. E., Cherubini, V., Tumini, S., Bonfanti, R., Buono, P., Cardella, F., d’Annunzio, G., Frongia, A. P., Lombardo, F., et al. (2013) · Acta Diabetologica · doi:10.1007/s00592-013-0521-7 · Cited by 22
The JDRF CCTN CGM TIME Trial: Timing of Initiation of continuous glucose Monitoring in Established pediatric type 1 diabetes: study protocol, recruitment and baseline characteristics
Lawson, M. L., Bradley, B., McAssey, K., Clarson, C. L., Kirsch, S. E., Mahmud, F. H., Curtis, J. R., Richardson, C., Courtney, J. M., Cooper, T., et al. (2014) · BMC Pediatrics · doi:10.1186/1471-2431-14-183 · Cited by 21
Cost-effectiveness of G5 Mobile continuous glucose monitoring device compared to self-monitoring of blood glucose alone for people with type 1 diabetes from the Canadian societal perspective
Chaugule, S., & Graham, C. (2017) · Journal of Medical Economics · doi:10.1080/13696998.2017.1360312 · Cited by 22
The road from intermittently scanned glucose monitoring to hybrid closed-loop systems: Part A. Keys to success: subject profiles, choice of systems, education
Ridder, F. D., den Brinker, M., & Block, C. E. M. D. (2019) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018819865399 · Cited by 22
Beyond A1C: exploring continuous glucose monitoring metrics in managing diabetes
Friedman, J. G., Coyne, K., Aleppo, G., & Szmuilowicz, E. D. (2023) · Endocrine Connections · doi:10.1530/ec-23-0085 · Cited by 22
Insulin pump therapy in youth with type 1 diabetes: toward closed-loop systems
Tauschmann, M., & Hovorka, R. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.910192 · Cited by 22
How Significant Is Severe Hypoglycemia in Older Adults With Diabetes?
Chow, L. S., & Seaquist, E. R. (2020) · Diabetes Care · doi:10.2337/dci19-0069 · Cited by 21
Exploring diazoxide and continuous glucose monitoring as treatment for Glut1 deficiency syndrome
Logel, S. N., Connor, E. L., Hsu, D., Fenske, R. J., Paloian, N. J., & Vivo, D. C. D. (2021) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51462 · Cited by 22
The role of continuous glucose monitoring in the care of children with type 1 diabetes
Larson, N. S., & Pinsker, J. E. (2013) · International Journal of Pediatric Endocrinology · doi:10.1186/1687-9856-2013-8 · Cited by 21
Clinical value of Flash glucose monitoring in patients with type 1 diabetes treated with continuous subcutaneous insulin infusion
Moreno-Fernández, J., Pazos-Couselo, M., González‐Rodríguez, M., Rozas, P., Delgado‐Rodríguez, M., Aguirre, M., & López, J. M. G. (2018) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2018.04.003 · Cited by 22
Cost-effectiveness of Initiating an Insulin Pump in T1D Adults Using Continuous Glucose Monitoring Compared with Multiple Daily Insulin Injections: The DIAMOND Randomized Trial
Wan, W., Skandari, M. R., Minc, A., Nathan, A. G., Zarei, P., Winn, A. N., O’Grady, M. J., & Huang, E. S. (2018) · Medical Decision Making · doi:10.1177/0272989x18803109 · Cited by 22
Use of sensor‐integrated pump therapy to reduce hypoglycaemia in people with Type 1 diabetes: a real‐world study in the UK
Choudhary, P., de Portu, S., Arrieta, A., Castañeda, J., & Campbell, F. (2019) · Diabetic Medicine · doi:10.1111/dme.14043 · Cited by 22
Weight Management in Youth with Type 1 Diabetes and Obesity: Challenges and Possible Solutions
Zaharieva, D. P., Addala, A., Simmons, K. M., & Maahs, D. M. (2020) · Current Obesity Reports · doi:10.1007/s13679-020-00411-z · Cited by 21
Use of continuous glucose monitoring and its association with type 1 diabetes control in children over the first 3 years of reimbursement approval: Population data from the ČENDA registry
Šumnı́k, Z., Pavlı́ková, M., Pomahačová, R., Venháčová, P., Petruželková, L., Škvor, J., Neumann, D., Vosáhlo, J., Konečná, P., Čížek, J., et al. (2021) · Pediatric Diabetes · doi:10.1111/pedi.13184 · Cited by 22
Self-citation
Integrated insulin pump therapy with continuous glucose monitoring for improved adherence: technology update
Tumminia, A., Sciacca, L., Frittitta, L., Squatrito, S., Vigneri, R., Le Moli, R., & Tomaselli, L. (2015) · Patient Preference and Adherence · doi:10.2147/ppa.s69482 · Cited by 20
“We must specify that, even if technology could deeply affect the patients’ lifestyle, it would be useless if not supported by a robust and continuous educational approach as demonstrated by the major randomized controlled trials on SAP therapy.(2,6,7) Perhaps the most important characteristic for predicting the best r…”
Parental Experiences of Continuous Glucose Monitoring in Danish Children with Type 1 Diabetes Mellitus
Haslund‐Thomsen, H., Hasselbalch, L. A., & Laugesen, B. (2020) · Journal of Pediatric Nursing · doi:10.1016/j.pedn.2020.03.010 · Cited by 20

Authors: the SWITCH Study Group, Battelino, T., Conget, I., Olsen, B., Schütz-Fuhrmann, I., Hommel, E., Hoogma, R., Schierloh, U., Sulli, N., & Bolinder, J.
Affiliations: University of Ljubljana (SI)
Glostrup Hospital (DK)
Klinik Hietzing (AT)
Groene Hart Ziekenhuis (NL)
Centre Hospitalier de Luxembourg (LU)
Karolinska University Hospital (SE)
Corresponding author: Battelino, T.
ORCID: Battelino, T.
Conget, I.
Olsen, B.
Hommel, E.
Schierloh, U.
Bolinder, J.
Venue: Diabetologia
Publisher: Springer Science and Business Media LLC
Published: 2012-09-11
Volume: 55
Issue: 12
Pages: 3155-3162
ISSN: 0012-186X (ISSN-L)
1432-0428
DOI: 10.1007/s00125-012-2708-9
PMC: PMC3483098
OpenAlex: W2075474575
Cited by: 494
References: 22
Citations by year: 2026: 14 · 2025: 20 · 2024: 28 · 2023: 27 · 2022: 27 · 2021: 52 · 2020: 52 · 2019: 52 · 2018: 53 · 2017: 44 · 2016: 39 · 2015: 28 · 2014: 30 · 2013: 25 · 2012: 1
FWCI: 21.56
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc
Locations: Diabetologia (publishedVersion, cc-by-nc)
Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
PubMed Central (publishedVersion, cc-by-nc)
PubMed (publishedVersion)
Open Repository and Bibliography (University of Luxembourg) (submittedVersion, cc-by-nc-sa)
IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords: continuous glucose monitoring, type 1 diabetes, insulin pump therapy, artificial pancreas, HbA1c, glycemic control, hypoglycemia, bolus insulin, children and adults, crossover trial, cost-effectiveness, quality of life
MeSH terms: Adolescent, Adult, Aged, Blood Glucose, Child, Diabetes Mellitus, Type 1, Female, Humans, Hyperglycemia, Hypoglycemic Agents, Insulin, Insulin Infusion Systems, Male, Middle Aged, Monitoring, Physiologic, Blood Glucose Self-Monitoring, Biosensing Techniques, Treatment Outcome, Cross-Over Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks